ProShare Advisors’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,020
Closed -$74.7K 2036
2025
Q2
$74.7K Buy
+10,020
New +$62.2K ﹤0.01% 1928
2025
Q1
Sell
-12,250
Closed -$95.3K 2136
2024
Q4
$95.3K Buy
+12,250
New +$91.3K ﹤0.01% 2084
2022
Q2
Sell
-7,605
Closed -$266K 1871
2022
Q1
$266K Sell
7,605
-1,256
-14% -$47.5K ﹤0.01% 1712
2021
Q4
$524K Buy
8,861
+3,661
+70% +$253K ﹤0.01% 1398
2021
Q3
$346K Sell
5,200
-5,322
-51% -$328K ﹤0.01% 1443
2021
Q2
$664K Sell
10,522
-153
-1% -$8.61K ﹤0.01% 1323
2021
Q1
$555K Buy
10,675
+2,937
+38% +$179K ﹤0.01% 1364
2020
Q4
$340K Buy
+7,738
New +$369K ﹤0.01% 1528

Other funds holding CYRX

ProShare Advisors's CYRX Position: Q3 2025 in Review

ProShare Advisors sold out of CryoPort (CYRX) in Q3 2025, closing a stake of 10,020 shares — an estimated $74.7K sold.

ProShare Advisors first reported a position in CYRX in Q4 2020 and held it in 8 quarters. The position peaked at $664K in Q2 2021. 160 funds tracked by Wall St. Rank hold CYRX as of Q3 2025.

  • ProShare Advisors reported no remaining CryoPort position as of Q3 2025 after selling out during the quarter.
  • ProShare Advisors sold 10,020 CryoPort shares in Q3 2025, an estimated $74.7K.
  • ProShare Advisors first reported a position in CryoPort in Q4 2020 and held it in 8 quarters.
  • ProShare Advisors's CryoPort position peaked at $664K in Q2 2021.
  • 160 funds tracked by Wall St. Rank held CryoPort as of Q3 2025.

Based on ProShare Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.